8 Needs context
Approximately 17 million babies worldwide have been born through in vitro fertilization (IVF).
"17 million babies have been born in this world because of IVF." (said at 1:07:40)
According to the most comprehensive global epidemiological analysis by the International Committee for Monitoring Assisted Reproductive Technologies (ICMART), an estimated 9.8 million to 13.0 million infants were born worldwide via assisted reproductive technologies (ART/IVF) between 1978 and 2018. With global ART activity generating over 800,000 to 900,000 infants annually in subsequent years (as reported in the 2019 ICMART report), cumulative worldwide estimates reach approximately 14 to 17 million births today. While 17 million reflects an upper-bound or extrapolated contemporary figure, published historical registry analyses specifically document 10 to 13 million through 2018.
- context: How many infants have been born with the help of assisted reproductive technology? (Fertility and sterility 2025) · cited 46x in the literature
"The global lower and upper estimates of infants born from ART from 1978 through 2018 are 9,829,668 and 13,019,331. Ten million and up to 13 million or more infants have been born from ART in the 40 years since the first ART-conceived infant was born in 1978." (abstract, results, passage verified)
pubmedfull study (doi) - context: International Committee for Monitoring Assisted Reproductive Technologies world report: as… (Fertility and sterility 2025) · cited 26x in the literature
"There were an estimated ≥3,855,694 cycles with >865,914 infants in reporting countries including nonreporting clinics. The reported number of cycles and infants increased by approximately 8% from 2018." (abstract, results)
pubmedfull study (doi)
Human body temperature must decrease by about 1 to 3 degrees to fall asleep and stay deeply asleep, and must increase by about 1 to 3 degrees to wake up.
"And that's because in order to fall asleep and stay deeply asleep, your body temperature actually has to drop by about 1 to 3°. And in order to wake up feeling refreshed and energized, your body temperature actually has to increase by about 1 to 3°." (said at 1:15:37)
The claim accurately describes the fundamental circadian pattern of thermoregulation in sleep, but requires clarification regarding units and physiology. Normal human core body temperature (CBT) fluctuates by approximately 0.5°C to 1.0°C (roughly 1°F to 2°F, up to ~3°F) across the 24-hour cycle. In the evening, vasodilation of peripheral/distal blood vessels dissipates core heat through the skin, lowering CBT to promote sleepiness and sleep onset. CBT reaches its nadir during late-night sleep and begins rising in the early morning hours to promote awakening. However, if interpreted in Celsius, a 1°C to 3°C drop is exaggerated (a 3°C drop would represent clinical hypothermia), and thermoregulatory heat redistribution to the periphery is the primary trigger of sleep initiation rather than CBT maintenance alone.
The combination birth control pill has a biological half-life of 28 hours.
"However, the half-life of the birth control pill is only 28 hours. So it's actually quite short." (said at 1:22:50)
A combined oral contraceptive pill contains two distinct active ingredients—an estrogen (typically ethinylestradiol) and a progestin (such as levonorgestrel, drospirenone, or norethindrone)—each with its own elimination half-life rather than a single unified value. However, the speaker's figure of approximately 28 hours accurately reflects the terminal elimination half-life of common progestin components (for example, levonorgestrel typically exhibits an elimination half-life of ~25–35 hours, while ethinylestradiol averages ~10–20 hours). This short duration necessitates daily dosing and explains the rapid decrease in circulating drug levels after missed doses.
A levonorgestrel-releasing (progesterone) intrauterine device typically suppresses ovulation during the first two years of use, after which progesterone levels decline and ovulation typically resumes.
"It typically suppresses ovulation in the first 2 years, but then progesterone levels drop and it tends not to suppress ovulation, but that chronic progesterone exposure thins the endometrial lining to the degree that many women do not have periods anymore." (said at 1:25:40)
The speaker accurately describes the general pharmacodynamics of levonorgestrel-releasing intrauterine devices (LNG-IUDs): higher systemic progestin levels initially lead to higher rates of anovulation, which decrease as release rates decline over time, and amenorrhea is driven by local endometrial suppression rather than persistent systemic anovulation. However, two details require context: (1) the active agent is levonorgestrel (a synthetic progestin, not endogenous progesterone), and (2) ovulation suppression is most prominent in the first few months to first year rather than fully suppressing ovulation for two years (studies show roughly 45% of cycles are already ovulatory within the first year, rising to >75-90% in subsequent years).
- context: Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine devic… (Contraception 1990) · cited 111x in the literature
"Among the 29 treatment cycles, there were 10 D-type, 3 C-type, 13 B-type and 3 A-type of ovarian reactions: 44.8% of the cycles were ovulatory (C + D) and 55.2% were anovulatory (A + B). In general, serum levels of levonorgestrel were low in ovulatory cycles and were high in anovulatory cycles... The decline of serum LNG from the 1st (492 pmol/l) to the 6th (320 pmol/l) treatment months was 34.9% on average. The amenorrheic cycles coincided mostly with the hormonal profile of ovulatory types, which indicated that the cause of amenorrhea is due to the local effect of levonorgestrel on the endometrium." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Levonorgestrel plasma concentrations and hormone profiles after insertion and after one ye… (Contraception 1980) · cited 78x in the literature
"The mean +/- SD plasma concentration of levonorgestrel for all subjects during the first three months was 260 +/- 68 pg/ml, and 129 +/- 28 pg/ml after one year of treatment. During the initial period of blood sampling only two of the subjects ovulated, while only two did not ovulate after one year of treatment." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual p… (Contraception 1995) · cited 77x in the literature
"Higher percentages of ovulatory cycles (78.5%) were found after 6 years of use. No case of complete suppression of ovulation was found... It is concluded that over two-thirds of the cases have ovulatory cycles after long-term use of Lng-IUD; the contraceptive effect is mainly due to its local action on the endometrium, with much less effect on the ovarian function." (abstract, results)
pubmedfull study (doi)
The lifespan of sperm is approximately 90 days, and the human egg is most susceptible to environmental influences during the 60 days prior to conception.
"when we know the lifespan of a sperm is 90 days and sperm are so sensitive. And then we know that even though eggs are in your body your whole life, the 60 days before you get pregnant is when the egg is most susceptible to the world around you." (said at 1:32:40)
The speaker conflates the developmental/maturation cycles of gametes with their cellular lifespan, though the timeframes roughly reflect standard reproductive biology. Human spermatogenesis takes approximately 74 days within the seminiferous tubules plus 10–14 days of epididymal maturation and transport (~90 days in total). Mature sperm survive only 3 to 5 days in the female reproductive tract. For oocytes, while primordial follicles are present from birth, the final stages of antral follicular growth and cytoplasmic/nuclear maturation take approximately 60 to 90 days (2 to 3 menstrual cycles) prior to ovulation, representing a recognized critical periconceptional window of heightened metabolic activity and vulnerability to nutritional, toxic, and environmental exposures.
Men who get less sleep exhibit lower testosterone levels and lower sperm counts.
"And we know really directly, men who get less sleep, they have lower testosterone levels and lower sperm counts." (said at 1:33:35)
Observational cohort studies show that short sleep duration and sleep disturbances are associated with lower total sperm count and semen volume, typically following an inverted U-shaped curve where both short (≤6.5 hours) and long (≥9 hours) sleep are linked to poorer semen quality. However, evidence regarding testosterone is mixed: while some acute laboratory sleep restriction studies observed daytime testosterone reductions, larger observational cohorts and subsequent randomized trials have found no significant association or adverse effect of sleep restriction on resting testosterone levels.
- supports: Association of sleep disturbances with reduced semen quality: a cross-sectional study amon… (American journal of epidemiology 2013) · cited 101x in the literature
"Sleep disturbances showed an inverse U-shaped association with sperm concentration, total sperm count, percent motile and percent morphologically normal spermatozoa, and testis size. Men with a high level of sleep disturbance (score >50) had a 29% (95% confidence interval: 2, 48) lower adjusted sperm concentration" (abstract, results, passage verified)
pubmedfull study (doi) - partial: Inverse U-shaped Association between Sleep Duration and Semen Quality: Longitudinal Observ… (Sleep 2016) · cited 100x in the literature
"There was a substantial inverse U-shaped association between sleep duration and two semen parameters (semen volume and total sperm number), with 7.0-7.5 h/day of sleep showing highest parameters. Either longer or shorter sleep was associated with decreased semen parameters in a dose-response manner (P = 0.002 and 0.001, respectively)... No association found between sleep duration and reproductive hormone." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Sleep restriction and testosterone concentrations in young healthy males: randomized contr… (Sleep health 2019) · cited 26x in the literature
"Sleep restriction does not adversely affect plasma testosterone levels in healthy young men. Given prior contradicting evidence, confirmatory studies should be done to ascertain the influence of sleep duration and quality on testosterone concentrations in men throughout life." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Taking 300 micrograms or more of biotin supplementation for seven days interferes with laboratory assays for steroid and thyroid hormones, including estradiol, progesterone, hCG, TSH, and testosterone.
"Taking a biotin supplementation of 300 micrograms or more for seven days can actually influence your lab assays for sex hormones or for any steroid hormone, actually... So this can happen to estradiol, to progesterone, to hCG, to TSH, to testosterone." (said at 2:16:47)
The speaker's general point is accurate: biotin supplementation causes significant analytical interference in streptavidin-biotin-based immunoassays commonly used to measure endocrine biomarkers, including thyroid hormones (e.g., TSH) and steroid/sex hormones (e.g., estradiol, progesterone, testosterone, and hCG). In sandwich immunoassays (such as TSH and hCG), excess biotin causes falsely low results, whereas in competitive immunoassays (such as steroid hormones), excess biotin causes falsely high results. However, the dose threshold mentioned by the speaker (300 micrograms) is very low: while standard multivitamin doses are around 30–300 mcg, documented clinically meaningful assay interference typically occurs at high pharmacological doses (often 5 mg to 10 mg or higher, or in mega-dose supplements/treatments). Non-streptavidin assays and mass spectrometry methods (LC-MS/MS) remain unaffected.
- supports: BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE… (Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017) · cited 114x in the literature
"The recent, marked, increase in the use of over-the-counter, high-dose biotin supplements has been accompanied by a steady increase in the number of reports of analytical interference by exogenous biotin in the immunoassays used to evaluate endocrine function." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healt… (JAMA 2017) · cited 129x in the literature
"Among the 2 women and 4 men (mean age, 38 years [range, 31-45 years]) who took 10 mg/d of biotin for 7 days, biotin ingestion-associated interference was found in 9 of the 23 (39%) biotinylated assays compared with none of the 14 nonbiotinylated assays (P = .007). Results from 5 of 8 biotinylated (63%) competitive immunoassays tested falsely high and results from 4 out of 15 (27%) biotinylated sandwich immunoassays tested falsely low." (abstract, results, passage verified)
pubmedfull study (doi)
Thermal paper receipts are one of the top sources of human exposure to bisphenol A (BPA).
"like one of the top exposures of BPA right now is actually thermal paper, so receipts." (said at 2:21:54)
Dietary intake (especially via canned food and food-contact materials) is established as the predominant route of bisphenol A (BPA) exposure in the general population, accounting for approximately 90% of total internal exposure. Thermal paper receipts represent the main non-dietary and dermal exposure source (accounting for >98% of paper-based exposures and around 10% of aggregate exposure in certain age groups), and can be a substantial exposure source in occupationally exposed workers such as cashiers.
- context: Widespread occurrence of bisphenol A in paper and paper products: implications for human e… (Environmental science & technology 2011) · cited 390x in the literature
"The daily intake of BPA (calculated from median concentrations) through dermal absorption from handling of papers was 17.5 and 1300 ng/day for the general population and occupationally exposed individuals, respectively; these values are minor compared with exposure through diet. Among paper products, thermal receipt papers contributed to the majority (>98%) of the exposures." (abstract, results, passage verified)
pubmedfull study (doi) - context: Including non-dietary sources into an exposure assessment of the European Food Safety Auth… (Regulatory toxicology and pharmacology : RTP 2017) · cited 59x in the literature
"Dietary exposure, especially via canned food, appears to be the most important exposure source and, based on the central aggregate exposure estimates, contributes around 90% to internal exposure to total (conjugated plus unconjugated) BPA. Dermal exposure via thermal paper and to a lesser extent via cosmetic products may contribute around 10% for some age groups." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.